Heparin Sodium and Sodium Chloride

Manufacturer
Baxter Healthcare Corporation | Baxter Healthcare Ltd
Effective date
2020-07-27
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 23:20:14

Label at a glance#

ProductHeparin Sodium and Sodium Chloride
Active ingredientHEPARIN SODIUM
Label structure2 sections

Label contents#

Full prescribing information#

HEALTH CARE PROVIDER LETTER

HEALTH CARE PROVIDER LETTER SECTION

DHCP Letter 1
DHCP Letter 1
DHCP Letter 2
DHCP Letter 2
DHCP Letter 3
DHCP Letter 3
DHCP Letter 4
DHCP Letter 4
DHCP Letter 5
DHCP Letter 5
DHCP Letter 6
DHCP Letter 6
DHCP Letter 7
DHCP Letter 7
DHCP Letter 8
DHCP Letter 8
DHCP Letter 9
DHCP Letter 9
DHCP Letter 10
DHCP Letter 10
DHCP Letter 11
DHCP Letter 11
DHCP Letter 12
DHCP Letter 12
DHCP Letter 13
DHCP Letter 13
DHCP Letter 14
DHCP Letter 14

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Container Label
Container Label

Code B0953G
500 ml
Baxter Logo
Heparin Sodium BP 2000 IU/L in
0.9% w/v Sodium Chloride IV Infusion

VIAFLEX container

Sterile nonpyrogenic
Solution for Infusion
Single Dose

Each 500 ml contains
Heparin Sodium (Mucous) 1000 IU
Sodium Chloride 4.5 g
Disodium Phosphate 12H 2 0 2.9 g
Citric Acid (Monohydrate) 0.202g
Water for Injections

mmol per 500 ml (approx)
Sodium 93
Chloride 77
Phosphate 8
Citrate 1

For intravenous administration
Store out of reach and sight of children
Do not remove from overwrap until ready for use
Do not use unless solution is clear and container is
undamaged
Do not add any supplementary medication
For use under medical supervision
Do not store above 25°C
Discard any unused portion
Do not reconnect partially used bags
Baxter Healthcare Ltd
Thetford Norfolk IP24 3SE
PL00116/0130
POM symbol
Heparin Sodium BP 2000 IU/L in
0.9% w/v Sodium Chloride
IV Infusion

TH-35-01-749
Lot
Expiry
1
2
3
4

Container Label
Container Label

Code B0944
1000 ml
Baxter Logo
Heparin Sodium BP 2000 IU/L in
0.9% w/v Sodium Chloride IV Infusion

VIAFLEX container
Sterile nonpyrogenic
Solution for Infusion
Single Dose

  1. Each 1000 ml contains
    Heparin Sodium (Mucous) 2000 IU
    Sodium Chloride 9 g
    Disodium Phosphate 12H 2 0 5.8 g
    Citric Acid (Monohydrate) 0.405 g
    Water for Injections

mmol per 1000 ml (approx)
Sodium 186
Chloride 154
Phosphate 16
Citrate 2

For intravenous administration
Store out of reach and sight of children
Do not remove from overwrap until ready for
use
Do not use unless solution is clear and container
is undamaged
Do not add any supplementary medication
For use under medical supervision
Do not store above 25°C
Discard any unused portion
Do not reconnect partially used bags

Baxter Healthcare Ltd
Thetford Norfolk IP24 3SE
PL00116/0130
POM symbol
TH-35-01-237

Heparin Sodium BP 2000 IU/L in
0.9% w/v Sodium Chloride
IV Infusion

Lot
Expiry
1
2
3
4
5
6
7
8
9

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0338-9556-20ML - Milliliter0338-9556def12cc4-1ca2-4ba8-8967-627e2f31439a12018-01-12
0338-9552-10ML - Milliliter0338-9552853bf164-909e-4858-9c6d-3bb0f9dad09712018-02-20

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0338-95560338-9556-20
0338-95520338-9552-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
02bfe934-cfd5-4fa5-be8d-54a475f0541ecf6ce51b-dc0c-424e-9fac-e4713bd095ed2020-07-27Exact identifier
spl id: 02bfe934-cfd5-4fa5-be8d-54a475f0541e
spl set id: cf6ce51b-dc0c-424e-9fac-e4713bd095ed

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.